Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 8, Issue 5, Pages 398-403Publisher
CURRENT SCIENCE INC
DOI: 10.1007/s11882-008-0077-8
Keywords
-
Categories
Funding
- National institutes of Health (NIH) [NO1-AR-2-2263, RO1 AR44422]
- National Institute of Arthritis, Musculoskeletal, and Skin Diseases
- NIH Clinical Research Program
Ask authors/readers for more resources
Recent advances in genetics and technology have led to breakthroughs in understanding the genes that predispose individuals to autoimmune diseases. A common haplotype of the signal transducer and activator of transcription 4 (STAT4) gene has been shown to be associated with susceptibility to rheumatoid arthritis, systemic lupus erythematosus, and primary Sjogren's syndrome. STAT4 is a transcription factor that transduces interleukin-12, interleukin-23, and type I interferon cytokine signals in T cells and monocytes, leading to T-helper type I and T-helper type 17 differentiation, monocyte activation, and interferon-gamma production. Although the evidence for this association is very strong and well replicated, the exact mechanism by which polymorphisms in this gene lead to disease remains unknown. In concert with the identification of other disease-associated loci, elucidating how the variant form of STAT4 modulates immune function should lead to an improved understanding of the pathophysiology of autoimmunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available